Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity

CCR5Δ32 mutations do not determine COVID-19 disease course

(2021) Stefanie N. Bernas et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

CCR5Δ32 Deletion as a Protective Factor in Czech First-Wave COVID-19 Subjects

(2021) J HUBACEK et al.   PHYSIOLOGICAL RESEARCH

Beyond HIV infection: neglected and varied impacts of CCR5 and CCR5Δ32 on viral diseases

(2020) Joel Henrique Ellwanger et al.   VIRUS RESEARCH

CCR 5 deficiency impairs CD 4 + T‐cell memory responses and antigenic sensitivity through increased ceramide synthesis

(2020) Ana Martín‐Leal et al.   EMBO JOURNAL

COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis

(2020) Robert Lorenz Chua et al.   NATURE BIOTECHNOLOGY

CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14

(2020) Bruce K. Patterson et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells

(2009) Helen KW Law et al.   BMC IMMUNOLOGY

Cellular Immune Responses to Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection in Senescent BALB/c Mice: CD4+ T Cells Are Important in Control of SARS-CoV Infection

(2009) J. Chen et al.   JOURNAL OF VIROLOGY

MyD88 Is Required for Protection from Lethal Infection with a Mouse-Adapted SARS-CoV

(2008) Timothy Sheahan et al.   PLoS Pathogens